Thomas Buhl

Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK

Rudolf Waelchli, Birgit Bollbuck, Christian Bruns et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 144 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Medicine +5

Estrogen Receptor Modulators:  Identification and Structure−Activity Relationships of Potent ERα-Selective Tetrahydroisoquinoline Ligands

Johanne Renaud, Serge Bischoff, Thomas Buhl et al. · Journal of Medicinal Chemistry · 2003 · 88 citations · Full text

High Throughput, Pharmacotherapy, Pharmaceutical Chemistry +17

Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity

Láśzló Révész, Ernst Blum, Franco E. Di Padova et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 77 citations · Full text

Medicine, Drug Discovery, Oral Activity +5

Prokinetic benzamides stimulate peristaltic activity in the isolated guinea pig ileum by activation of 5-HT4 receptors

Karl‐Heinz Buchheit, Thomas Buhl · European Journal of Pharmacology · 1991 · 74 citations

Gastrointestinal Peptide Hormone, Biochemistry, Medicine +9

Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine.

Thomas Buhl, L. Thim, Hans Kofod et al. · Journal of Biological Chemistry · 1988 · 72 citations · Full text